Detailed comparison of Ozempic (Semaglutide) and Wegovy (Semaglutide) — mechanisms, dosing, side effects, costs, and best use cases.
| Factor | Ozempic (Semaglutide) | Wegovy (Semaglutide) |
|---|---|---|
| Category | GLP-1 / Diabetes | GLP-1 / Weight Loss |
| Common Dose | 250–2,000 mcg | 250–2,400 mcg |
| Frequency | Once weekly | Once weekly |
| Half-Life | ~7 days | ~7 days |
| Best For | Type 2 diabetes management. Cardiovascular risk reduction. Max dose: 2 mg. | Chronic weight management. Obesity treatment. Max dose: 2.4 mg. |
GLP-1 / Diabetes
Ozempic is the brand name for semaglutide (up to 2 mg weekly), FDA-approved for type 2 diabetes and cardiovascular risk reduction. Chemically identical to Wegovy but at diabetes doses. Its remarkable weight loss effects — averaging 10–15% even at diabetes doses — sparked the global GLP-1 weight loss...
Dose: 250–2,000 mcg
Frequency: Once weekly
⚡ Ozempic (Semaglutide) CalculatorGLP-1 / Weight Loss
Wegovy is semaglutide at 2.4 mg weekly — FDA-approved specifically for chronic weight management in adults with obesity or overweight with weight-related conditions. The STEP trials demonstrated average weight loss of ~15% body weight over 68 weeks. Wegovy is the clinical standard for GLP-1-based we...
Dose: 250–2,400 mcg
Frequency: Once weekly
⚡ Wegovy (Semaglutide) CalculatorOzempic and Wegovy are the same molecule (semaglutide) at different FDA-approved doses and indications. Wegovy (2.4 mg) is approved for weight loss; Ozempic (up to 2 mg) is approved for diabetes.
Ozempic is the brand name for semaglutide (up to 2 mg weekly), FDA-approved for type 2 diabetes and cardiovascular risk reduction. Chemically identical to Wegovy but at diabetes doses. Its remarkable weight loss effects — averaging 10–15% even at diabetes doses — sparked the global GLP-1 weight loss revolution. Many use it off-label for weight management. Compounded semaglutide has replicated Ozempic's efficacy at lower cost. Track your weekly Ozempic doses with DoseIQ.
📖 Read Full Ozempic (Semaglutide) Dosing Guide →Wegovy is semaglutide at 2.4 mg weekly — FDA-approved specifically for chronic weight management in adults with obesity or overweight with weight-related conditions. The STEP trials demonstrated average weight loss of ~15% body weight over 68 weeks. Wegovy is the clinical standard for GLP-1-based weight management. Same molecule as Ozempic but at higher approved doses. Compounded semaglutide at 2.4 mg weekly replicates Wegovy's profile. Track your Wegovy titration schedule with the DoseIQ app.
📖 Read Full Wegovy (Semaglutide) Dosing Guide →The #1 peptide tracking app for iPhone. Calculate doses, log injections, set reminders, and track your progress.
⬇️ Download Free on App Store